GLTO Chart
- 52-Week Range: $1.39 - $8.00
- Market Capitalization: $35.87M
- Short Percentage: 0%
- Target Price: $11.25
- Shares Outstanding: 25.26M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GLTO released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Galecto Completes Enrollment in Global Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of IPFGlobeNewsWire | April 26th
- Galecto Reports Financial Results for the Year Ended December 31, 2021GlobeNewsWire | February 17th
- Galecto to Present at 2021 Cantor Virtual Global Healthcare ConferenceGlobeNewsWire | September 15th
- Galecto Announces First Patient Treated in Phase 2 Trial of Oral Galectin-3 Inhibitor GB1211 in Liver CirrhosisGlobeNewsWire | September 13th
Company Info
Website: https://galecto.com
Address: 75 State Street, Boston, MA, United States, 02109
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
Address: 75 State Street, Boston, MA, United States, 02109
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
$GLTO has just been halted from trading due to volatility.
$GLTO I REALLY THINK WE FINALLY HAVE OUR FIRESALE?? !!
$GLTO nice gap
$GLTO LOADING UP HERE!
$GLTO Reinvest your dividends
$GLTO coming now
$GLTO When they tell me diversifying is for idiots
$GLTO has just been halted from trading due to volatility.
$GLTO has just been halted from trading due to volatility.
$GLTO has just been halted from trading due to volatility.